Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share ... (Diluted 12818...)

Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share Repurchase

Date:8/17/2009

Diluted 128,188,815 119,050,014 119,050,014 SIMCERE PHARMACEUTICAL GROUP UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (AMOUNTS EXPRESSED IN THOUSANDS) December 31, June 30, June 30, 2008 2009 2009 RMB RMB USD Assets Current assets Cash, cash equivalents and restricted cash 813,766 636,337 93,166 Accounts and bills receivables, net 748,997 638,060 93,417 Inventories 95,948 111,222 16,284 Other current assets 49,048 80,753 11,822 Total current assets 1,707,759 1,466,372 214,689 Property, plant and equipment, net 463,059 500,318 73,251 Land use rights 114,624 113,385 16,601 Goodwill and intangible assets, net 453,455 439,199 64,303 Investment in an affiliated company -- 195,540 28,629 Other assets 39,325 37,967 5,558 Total assets 2,778,222 2,752,781 403,031 Liabilities Current liabilities Short-term borrowings and current installments of long-term debt 6,000 6,000 878 Accounts and bills payables 25,219 30,587 4,478 Other payables and accrued liabilities 303,794 394,458 57,754 Total current liabilities 335,013 431,045 63,110 Long-term debt, excluding current installments 62,000 62,000 9,077 De

SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/15/2009)... potential for injury when doctors decide benefits of imaging ... -- MRI scans can pose a serious risk to ... and Drug Administration researchers exposed pacemakers to a simulated ... produced at the tip of the pacemaker lead, where ... , The exposure to MRI magnetic pulses caused certain ...

(Date:12/15/2009)... as accurate a surgical method, with fewer complications, analysis ... it comes to diagnosing breast cancer, women and their ... the less invasive "core needle biopsy" procedure is nearly ... surgical procedure is, with fewer complications than the surgical ... the Jan. 5 issue of Annals of Internal ...

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... the U.S. and its International Trade ... http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The newly published ... provides the latest market research on ...

(Date:12/15/2009)... SMITHFIELD, R.I., Dec. 15 Mergers and ... to expand their reach globally or complete a ... including the integration of safety programs. ,, A ... " Best Practices in a Hearing Conservation Program: ... US Airways and America West led the newly ...

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... has released its latest research "The ...

[0] Patients With Pacemakers Should Avoid MRI Scans [0] Needle Biopsy Works Well in Diagnosing Breast Cancer [0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways [0] Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... ,MemorialCare is joining forces with its physician partners ... to the hard hits health care,providers have been ... Medi-Cal reimbursement cuts to physicians, as well as ... inpatient,services., In efforts to continue to build ...

... Miami resident,Rita Campos Ramirez, 60, was sentenced to 10 ... scheme to defraud Medicare, Assistant Attorney General,Alice S. Fisher ... of the Southern District of Florida announced today. The ... in the,history of the program., Campos was sentenced ...

... Thanks to a,bipartisan compromise brokered by Foreign Affairs ... voted overwhelmingly to expand the,landmark U.S. effort to ... has saved millions of lives., Despite efforts ... the,funding it provides, the Tom Lantos and Henry ...

... The following,statement was issued today by AMA President Ron ... U.S. House Energy and,Commerce Committee for passing the "Family ... full House to take a critical step to,combat smoking-related ... needed regulatory authority over tobacco products., "Given what ...

... April 2, 2008 Speaker Nancy,Pelosi spoke on the ... Against HIV/AIDS, Tuberculosis, and Malaria Act, which provides,$50 billion ... around,the world. Below are the Speaker,s remarks:, "I ... this is the first,piece of legislation to come out ...

... State University public,relations students organized a flash mob on ... donors. April is National Donate Life Month., (Photo: ... defined as: "A large group of people who assemble,suddenly ... a brief period of,time, then quickly disperse." The goal ...

Other Medicine News:Health News:MemorialCare Joins Forces with Physician Partners to Advocate for a Balanced, Fiscally Responsible Healthcare System 2 Health News:Owner of Medicare Billing Service Sentenced to 10 Years In Prison For Role in $170 Million Medicare Fraud Scheme 2 Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 2 Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 3 Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 2 Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 3 Health News:Kent State Public Relations Students Host a Flash Mob to Launch National Donate Life Month 2

MemorialCare Joins Forces with Physician Partners to Advocate for a Balanced, Fiscally Responsible Healthcare System Owner of Medicare Billing Service Sentenced to 10 Years In Prison For Role in $170 Million Medicare Fraud Scheme House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort AMA Applauds House Committee Passage of Tobacco Regulation Bill; Calls for Full House Passage Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic'Kent State Public Relations Students Host a Flash Mob to Launch National Donate Life Month

(Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 NxStage Medical, ... of innovative dialysis products, today announced that a ... partners will be embarking on a week-long, conventional ... cyclers. The cruise, dubbed the "2010 Freedom ... from Miami, Fla. on January 3, 2010 and ...

(Date:12/15/2009)... -- Vivakor, Inc. (OTC Bulletin Board: VIVK) ... strong performance in 2009. Vivakor is a ... divisional spokes developing multiple products and technologies ... is anchored to the concept of licensing ... R&D efforts target commercialization and product-specific exit ...

(Date:12/15/2009)... NEW HAVEN, Conn., Dec. 15 Rib-X ... development and commercialization of novel drugs for the ... has entered into a collaborative research agreement with ... the science plan for the collaboration, Dr. David ... delafloxacin, in an established animal model to determine ...

Breaking Medicine Technology:Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2 Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3 Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4 Vivakor Divisions Continue to Demonstrate Independent Growth 2 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3 New test for safer biomedical research results 53248 1 New test for safer biomedical research results 53248 2 Food additive may one day help control blood lipids and reduce disease risk 53243 1 Food additive may one day help control blood lipids and reduce disease risk 53243 2 Food additive may one day help control blood lipids and reduce disease risk 53243 3 Leicester research paves way for first use in Europe of an insect to fight invasive plant 9429 1 Leicester research paves way for first use in Europe of an insect to fight invasive plant 9429 2 Leicester research paves way for first use in Europe of an insect to fight invasive plant 9429 3

[0] Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)[0] Vivakor Divisions Continue to Demonstrate Independent Growth [0] Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital

... RESPONSE RATE- MEDIAN SURVIVAL OF 10.5 MONTHS IN ... ANNUAL MEETINGSOUTH SAN FRANCISCO, Calif., March 3 ... announced new positive preliminary efficacy results from a ... clinical trial evaluating Marqibo(R) (vincristine sulfate liposomes injection) ...

... 3 Novexel, a speciality pharmaceutical,company focused ... antibiotics,designed to overcome the significant global problem ... advanced injectable antibacterial, which,combines Novexel,s broad spectrum ... cephalosporin antibiotic, ceftazidime, has entered a second,Phase ...

Other Medicine Technology:Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 2 Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 3 Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 4 Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 5 Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 2 Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 3 Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 4

Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)

... BAK/C cervical interbody fusion system represents a ... of the cervical spine. The system gathers ... implantation. The self-packing of bone into the ... the need to harvest from the iliac ...

Signa Profile is built on the Signa foundation to deliver speed & image quality....

... instrument set consisting of 38 cobbs, ... in the spine. The instruments extra ... These instruments, best applied in thoracic, ... ideal option for surgeons to pick ...

... has an extensive base of experience and ... gel. When concentrated autologous platelets are mixed ... and functional changes involved in coagulation take ... number of factors including serotonin, fibronectin, adenosine ...

Medicine Products:

BAK/C Signa Profile 0.2T Spinal Instruments Autologous Platelet Gel

Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share ...(Diluted 12818...),Health